Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa
South Africa diagnoses almost 20,000 patients with Rifampicin-resistant tuberculosis each year. A research team comprising Helen Cox (University of Cape Town), AIGHD researchers Anja van’t Hoog and Frank Cobelens, and other colleagues assessed the impact of the Xpert MTB/RIF test (a rapid test for tuberculosis and...